Smu1 and RED are required for activation of spliceosomal B complexes assembled on short introns. by Keiper, S. et al.
ARTICLE
Smu1 and RED are required for activation
of spliceosomal B complexes assembled
on short introns
Sandra Keiper 1, Panagiotis Papasaikas 2,4,5, Cindy L. Will1, Juan Valcárcel2,3, Cyrille Girard1 &
Reinhard Lührmann1
Human pre-catalytic spliceosomes contain several proteins that associate transiently just
prior to spliceosome activation and are absent in yeast, suggesting that this critical step is
more complex in higher eukaryotes. We demonstrate via RNAi coupled with RNA-Seq that
two of these human-speciﬁc proteins, Smu1 and RED, function both as alternative splicing
regulators and as general splicing factors and are required predominantly for efﬁcient splicing
of short introns. In vitro splicing assays reveal that Smu1 and RED promote spliceosome
activation, and are essential for this step when the distance between the pre-mRNA’s 5′
splice site (SS) and branch site (BS) is sufﬁciently short. This Smu1-RED requirement can be
bypassed when the 5′ and 3′ regions of short introns are physically separated. Our obser-
vations suggest that Smu1 and RED relieve physical constraints arising from a short 5′SS-BS
distance, thereby enabling spliceosomes to overcome structural challenges associated with
the splicing of short introns.
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Spliceosome assembly is initiated by the stepwise recruitmentof the U1 and U2 snRNPs to the 5′ splice site (SS) andbranch site (BS), respectively, of an intron, generating the
spliceosomal A complex. Subsequently, the preformed U4/U6.U5
tri-snRNP binds1,2, yielding the B complex. Profound composi-
tional and conformational rearrangements, including loss of U4
and the exchange of more than 35 proteins, lead to the activated
Bact complex. Spliceosome activation is a multi-step process that
is initiated by unwinding of the U4/U6 duplex by the RNA
helicase Brr2. This allows U6 to rearrange and form the func-
tionally important U6 internal stem loop (ISL), and to establish
new base pairing interactions with U2 to form key catalytically
active U2/U6 RNA structures in the spliceosome. However, the
roles of other spliceosomal proteins in the complex activation
process, especially in higher eukaryotes, remains unclear. Sub-
sequent remodelling by the Prp2 helicase generates the B* com-
plex, which catalyses step 1 of pre-mRNA splicing, i.e. 5′SS
cleavage and intron lariat-3′ exon formation. The C complex,
formed during step 1, is activated to the C* complex, which
catalyses intron excision and ligation of the 5′ and 3′ exons
(step 2)2.
Most of the ~280,000 annotated human introns are longer than
70 nucleotides (nts), with only a small fraction (0.25%) shorter
than 73 nts3. Previous studies showed that intron length affects the
efﬁciency of splicing, with those introns shorter than 80 nts dis-
playing a clear reduction in splicing4,5. Moreover, a minimal
distance separating the 5′SS and BS—estimated to be ca 50 nts—is
required to allow efﬁcient spliceosome assembly and splicing4–9.
This minimal distance appears to be needed for the simultaneous
and productive binding of snRNPs to the 5′ and 3′ regions of
the intron, which otherwise would be sterically hindered. Indeed, a
5′SS–BS distance of 50 nts allows the assembly of early spliceo-
somal complexes on the adenovirus E1A pre-mRNA, but if
shortened to 35 nts, assembly is completely abolished7. The dis-
tance between the 5′SS and BS can also affect alternative splicing
events, as shown for the mutually exclusive splicing of exons of the
alpha-tropomyosin pre-mRNA9.
During B complex formation, several B-speciﬁc proteins (i.e.
RED, MFAP1, FBP21, Smu1, Prp38, Snu23, UBL5, NPW38 and
NPW38BP) interact with the spliceosome and are released/
destabilised already during the subsequent activation stage10.
Several B-speciﬁc proteins, including Smu1 and RED, have no
orthologs in the yeast Saccharomyces cerevisiae, suggesting that
their roles in splicing are conﬁned to regulatory tasks rather than
essential core functions. At least one of the B-speciﬁc proteins,
namely Prp38, is required for spliceosome activation in yeast11
and was suggested to play a similar role in humans12. The
B-speciﬁc proteins, Smu1 and RED, are conserved in higher
eukaryotes and they have been shown to modulate alternative
splicing in various organisms13–18. Smu1 and RED interact with
each other13,16,19–21 and they appear to directly stabilise each
other within the cell and function as a unit16,19. Smu1 and RED
have been implicated in other cellular processes aside from pre-
mRNA splicing, including mitotic spindle integrity22,23, genome
stability18,24–26, regulating mitotic kinases/phosphatases27, aiding
MAD1 localisation to kinetochores28 and binding to inﬂuenza
virus RNA polymerase19. Based on structural and yeast two-
hybrid studies, Smu1 and RED were proposed to act as a binding
platform that mediates multiple protein–protein interactions
within the spliceosome20,21. The recent cryogenic electron
microscopy (cryo-EM) structure of the human B complex shed
light on possible roles for Smu1 and RED, indicating that they
play an important structural role in bridging Brr2 with the U2
protein SF3B329. This observation challenges the notion that RED
and Smu1 solely play regulatory roles, suggesting instead a core
structural function during spliceosome assembly.
Knockdown of Smu1 or RED in human cells signiﬁcantly
changes alternative splicing patterns15. However, it was unclear
whether Smu1 and RED also play a role in constitutive splicing.
Here, we investigate the roles of the human Smu1 and RED
proteins in splicing and spliceosome assembly. We show that
RED and Smu1 knockdown not only affects alternative splicing
outcomes in vivo, but also leads to the retention of constitutively-
spliced introns, the majority of which are relatively short. We also
demonstrate that Smu1 and RED are important for efﬁcient
splicing in vitro, and that the splicing of short introns with a
minimum 5′SS–BS distance is abolished when Smu1 and RED are
absent. Our data demonstrate that Smu1 and RED play important
roles during spliceosome activation, and likely help to relieve
structural constraints that hinder activation of spliceosomes
formed on introns with a short 5′SS–BS distance.
Results
Smu1 and RED knockdown hinders the splicing of short
introns. To elucidate the role of Smu1 and RED, we investigated
global effects on pre-mRNA splicing after their knockdown in
HeLa cells using RNAi followed by RNA-Seq analysis. Cells were
transfected with siRNAs speciﬁc for Smu1, RED or, for com-
parison, the B complex-speciﬁc protein MFAP1. Total RNA was
harvested 50 h post transfection and subjected to paired-ended
Illumina sequencing. Western blotting revealed a 70–80%
decrease in Smu1, RED or MFAP1 in the knockdown cells
compared to control cells (Supplementary Fig. 1a), and that
knockdown of Smu1 leads to a substantial decrease in RED and
vice versa (Supplementary Fig. 1b). Consistent with previous
results obtained using multiplexed reverse transcription poly-
merase chain reaction (RT-PCR) analysed by capillary electro-
phoresis (LabChip)15, Smu1 or RED depletion led to changes in
the alternative splicing (AS) of cassette exons (Cex) (Fig. 1a), the
majority of which were skipped (Supplementary Fig. 1c) or in the
selection of alternative 5′ and 3′ splice sites (Fig. 1a). Strikingly,
21–23% of the changes in splicing observed in ΔSmu1 and ΔRED
cells involved the retention of introns (RI), the vast majority
(>90%) of which are constitutively-spliced introns (Fig. 1b,
Supplementary Data 1). This demonstrates that Smu1 and RED
also function as more general splicing factors. MFAP1 knock-
down also affected alternative and constitutive splicing to a
similar extent, but in many cases led to changes in the splicing of
different subsets of introns (Supplementary Fig. 1d), suggesting
differential roles for the B-speciﬁc proteins during splicing
(Fig. 1a, c). Consistent with Smu1 and RED functioning as a unit
during constitutive splicing, the overlap of introns retained after
either Smu1 or RED knockdown was strikingly high (75%),
whereas the overlap between knockdown of either of them and
that of MFAP1 was only ca 25% (Supplementary Fig. 1d).
Close inspection of the introns retained upon Smu1 or RED
knockdown did not reveal common sequence motifs, or features
such as a higher or lower percent of GC nucleotides. However, the
majority of these introns were relatively short. In ΔSmu1 and
ΔRED cells, approximately 60% of the retained introns were
shorter than 200 nts, although such short introns represent only
~15% of introns annotated in the human genome (Fig. 1c). In
comparison, only 20% of introns retained upon MFAP1 knock-
down were shorter than 200 nts (Fig. 1c). Furthermore, introns
with the highest retention levels in ΔSmu1 and ΔRED cells had, in
most cases, lengths between 75 and 100 nts (Supplementary
Fig. 1e). Close inspection of the distribution of distances between
the 5′SS and BS showed that short introns retained upon Smu1 or
RED knockdown display a peak between 50 and 70 nts, while
short introns unaffected by Smu1/RED depletion displayed a
wider distribution of 5′SS–BS distances, as was also the case for
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Fig. 1 Knockdown of Smu1 and RED leads to the retention of constitutively spliced introns. a Pie charts showing the distribution of different splicing events
altered in HeLa cells after knockdown of Smu1, RED or MFAP1, as determined by RNA-seq. Usage of alternatively spliced (Alt) 3′ or 5′ splice sites, changes
in the inclusion or skipping of cassette exons, and retention of introns are indicated. b Fraction of constitutively spliced introns among those retained
(unspliced) upon knockdown of Smu1, RED or MFAP1. c Introns were sorted into 4 classes according to their length—i.e. <200 bases, 200–1 Kb, 1–5 Kb and
>5 Kb. Charts showing the relative distribution of these 4 intron length classes in the genome or in those introns retained after Smu1, RED or MFAP1
knockdown. d 5′SS to BS distances in short introns (<250 nts long) retained after Smu1, RED or MFAP1 knockdown versus non-retained short introns with a
matching intron-length distribution. The observed distributions for retained versus non-retained (unaffected) short introns are signiﬁcantly different for
ΔSmu1 and ΔRED (p-value < 1e−12, two-sided, two sample Smirnov–Kolmogorov test), but not for ΔMFAP1 (p-value > 0.01)
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short introns either retained or unaffected by MFAP1 knockdown
(Fig. 1d, Supplementary Fig. 1f). Thus, we conclude that a short 5′
SS–BS distance is a feature associated with the sensitivity of
introns to depletion of Smu1 and RED in vivo.
Shortening the 5′SS–BS distance inhibits splicing in vitro. To
dissect the role of Smu1 and RED in the splicing of short introns,
we performed splicing in HeLa nuclear extract (NE) with MINX-
MS2 pre-mRNA and either truncated or extended versions
thereof (Fig. 2a). MINX pre-mRNAs with a 150, 90, 80 or 70 nts
long intron (referred to as MINX150, -90, -80 and -70, respec-
tively) were generated by removing or adding nts between the 5′
SS and the branch site of MINX120, but without altering the 15
nts directly downstream of the 5′SS or the 20 nts upstream of the
BS (Fig. 2a). As a result, the 5′SS is separated from the BS by 126,
96, 66, 56 and 46 nts in the MINX150, -120, -90, -80 and -70 pre-
mRNAs, respectively. Increasing intron length had no appreciable
effect on splicing (Supplementary Fig. 2a, c, compare MINX120
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90 or 80 nts, and thus the 5′SS–BS distance, slowed down the
kinetics of the splicing reaction. For example, 37% of the
MINX90, and only 20% of MINX80 was spliced after 30 min,
compared to ca 60% of MINX120 or MINX150 (Supplementary
Fig. 2a, c). Strikingly, when the MINX intron was shortened to 70
nt, leading to a 5′SS–BS distance of 46 nts, splicing was abolished
(Supplementary Fig. 2a, c). Native gel electrophoresis revealed a
delay in the formation of Bact and catalytically-active C complexes
on MINX90 and MINX80, which were detectable only after 30
min compared to detection at 10 min on MINX120 and
MINX150 (Supplementary Fig. 2b). The A to B and B to Bact
transitions were also less efﬁcient with MINX80, and appeared to
be severely impaired with MINX70 (Supplementary Fig. 2b),
indicating that the assembly of the spliceosome was compro-
mised. Our data are in agreement with previous studies indicating
that a minimum distance between the 5′SS and BS of approxi-
mately 50 nts is required for efﬁcient spliceosome assembly
in vitro.
Smu1/RED depletion hinders efﬁcient spliceosome activation.
To assess their roles in pre-mRNA splicing, we immunodepleted
Smu1 and RED from HeLa nuclear extract using an anti-Smu1
antibody. Consistent with them forming a highly stable dimer,
both Smu1 and RED were efﬁciently immunodepleted, whereas
the levels of other B-speciﬁc proteins such as MFAP1, FBP21 or
Prp38, and of core spliceosomal factors (Snu114, Snu66 and
SF3A2) were largely unaffected (Supplementary Fig. 3). Splicing
of MINX150, MINX120, MINX90 and MINX80 pre-mRNA was
substantially reduced in the ΔSmu1/RED versus mock-depleted
extract (Fig. 2b, d). For example, the amount of mRNA generated
with the MINX150, MINX120 and MINX90 pre-mRNAs was
71%, 62% and 56%, respectively, after 90 min in the mock-
depleted NE, but dropped to 44%, 45% and 33%, respectively, in
ΔSmu1/RED NE. Thus, Smu1 and RED are important for efﬁ-
cient splicing in vitro. The most dramatic effect was observed
with MINX80, where splicing was essentially abolished in
ΔSmu1/RED NE (Fig. 2b, d). Thus, when the 5′SS–BS distance
reaches a critical lower limit, splicing becomes highly dependent
on Smu1/RED. Analysis of spliceosome assembly revealed that
depletion of Smu1 and RED led to an accumulation of B com-
plexes compared to the mock, with all of the MINX pre-mRNAs
tested (Fig. 2c). This indicates that the B to Bact transition is
hindered in the absence of Smu1 and RED. This effect was most
prominent with MINX80, where the strong accumulation of B
complexes in ΔSmu1/RED extract remained constant over 90
min, suggesting that the activation of spliceosomes formed on
introns with a short 5′SS–BS distance is blocked when Smu1 and
RED are absent. Importantly, expanding the distance between the
BS and 3′SS of MINX-80 by 10 nts did not relieve this block
(Supplementary Fig. 4).
Similar results were obtained with the PM5 pre-mRNA (PM5-
211), which contains a 5′ exon followed by a 211 nts long intron,
but lacks a 3′ exon (Fig. 3a), blocking splicing after step 1. When
the distance between the 5′SS and BS of PM5 was shortened from
151 nts to 56 nts (i.e. the same distance as in MINX80),
generating PM5-116, splicing was nearly abolished in the ΔSmu1/
RED extract (Fig. 3b, d). There was also a clear accumulation of B
complexes, although they appeared to be somewhat less stable at
longer incubation times than those assembled on MINX80, and a
concomitant reduction in Bact/C complexes (Fig. 3c). These
results show that despite its 116 nts long intron, spliceosome
assembly on the PM5-116 pre-mRNA was also stalled at the B
complex stage, indicating that the distance separating the 5′SS
and the BS, and not the total intron length, determines whether
Smu1 and RED are essential for spliceosome activation.
Adding back puriﬁed Smu1/RED dimer (Supplementary
Fig. 5b), to ΔSmu1/RED extract fully restored both splicing of
the MINX80 pre-mRNA and spliceosome assembly (Fig. 4a, b).
This conﬁrms that the inhibitory effect on activation is due solely
to the absence of Smu1/RED and not other co-depleted factors.
Taken together, these data indicate that Smu1 and RED facilitate
Bact formation, and are essential for the activation of spliceosomes
assembled on introns with a short 5′SS–BS distance.
Both proteins are required for splicing in ΔSmu1/RED extract.
RED is a highly intrinsically-disordered protein, whereas Smu1
contains a C-terminal WD40 domain and an N-terminal region
that interacts with RED21 (Supplementary Fig. 4a). Cryo-EM,
which allowed the localisation of the N-terminal and WD40
domains of Smu1 but only a short α-helix of RED, revealed that
Smu1 and RED interact in the human B complex, forming a
bridge between the Brr2 helicase and U2 SF3B3 protein that
involves Smu1’s WD40 domain (Fig. 4c). To determine whether
Smu1 or RED alone sufﬁce for efﬁcient activation, we added each
protein individually to the ΔSmu1/RED extract and, after a 15
min preincubation, analysed splicing of MINX80. When Smu1 or
RED were added alone, the accumulation of B complexes per-
sisted and no increase in splicing was observed (Fig. 4d, e). In
contrast, the block in the B to Bact transition was alleviated and
there was an increase in spliced mRNA when the puriﬁed Smu1/
RED dimer, or both of the individual proteins were added toge-
ther (Fig. 4d, e). This is consistent with the idea that both proteins
act as a unit during splicing and that dimer formation is a pre-
requisite for the productive integration of each protein into the
spliceosome. To test the latter, we puriﬁed B complexes formed
on MINX80 pre-mRNA after addition of both Smu1 and RED, or
of each protein alone, to ΔSmu1/RED extract. Only relatively low
amounts of Smu1 or RED copuriﬁed with spliceosomes when
added individually, whereas association of these proteins was
greatly enhanced when both proteins were added together to the
splicing reaction (Fig. 4f). Thus, Smu1 and RED are dependent on
one another for productive association with spliceosomal B
complexes. Dimerisation might introduce structural changes in
Smu1 and/or RED that enable their proper/stable interaction with
Fig. 2 In the absence of Smu1/RED splicing is abolished when the 5′SS–BS distance is short. a Schematic of MINX-MS2 pre-mRNAs with varying intron
lengths. The MINX120 intron (120 nt) was extended by 30 nt (MINX150) or truncated by 30 nt (MINX90), 40 nt (MINX80) or 50 nt (MINX70). Variable
regions are illustrated in orange. Reactive sites (5′SS, BS, 3′SS) and the PY tract remained unchanged. b, c Kinetics of in vitro splicing (b) and spliceosome
assembly (c) in the presence or absence of Smu1/RED. 32P-labelled MINX pre-mRNAs were incubated under splicing conditions in the presence of mock-
depleted (i.e. treated in an identical manner but without antibody) or Smu1/RED-immunodepleted HeLa nuclear extract for 0–90min. In panel (b), RNA
was analysed by denaturing PAGE and visualised by autoradiography. The pre-mRNA and splicing intermediates and products are indicated on the left. The
asterisk and ‘x’ indicate the intron-3′exon intermediate or spliced-out intron of the various pre-mRNAs, which migrate differently due to their varying sizes.
In panel (c), spliceosomal complex formation was analysed on a native agarose gel and visualised by autoradiography. The positions of the H/E, A, B, C and
Bact complexes are indicated on the left. d Quantiﬁcation of the percent of spliced mRNA formed in mock-depleted (red line) or Smu1/RED-depleted
extract (blue line) at different time points with the indicated MINX pre-mRNAs. Error bars represent the standard deviation obtained from two independent
experiments. Source data are provided as a Source Data ﬁle
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other B complex components. Indeed, Smu1 from Caenorhabditis
elegans undergoes global conformational changes upon binding
to RED21.
Deletion of the C-terminal WD40 domain of Smu1 did not
affect Smu1/RED dimer formation, as evidenced by the
copuriﬁcation of the Smu1-ΔWD40 mutant together with His-
tagged RED after afﬁnity puriﬁcation with Ni-NTA beads
(Supplementary Fig. 5b). However, the Smu1-ΔWD40/RED
dimer no longer copuriﬁed with spliceosomes (Supplementary
Fig. 5e) and accordingly, failed to restore spliceosome assembly
and the catalytic steps of splicing to the levels observed with the
wildtype heterodimer (Supplementary Fig. 5c, d). Thus, Smu1’s
WD40 domain plays an important role in the recruitment of
Smu1 and RED to the B complex.
Characterisation of ΔSmu1/RED spliceosomal B complexes. To
investigate whether Smu1 and RED depletion affects the
recruitment of other spliceosomal proteins, we afﬁnity-puriﬁed
ΔSmu1/RED B complexes assembled on MINX80. For compar-
ison, B complexes assembled in mock-depleted extract after 8 min
(kinetically-stalled B complexes) were also puriﬁed. Gradient
centrifugation of the 8 min splicing reactions prior to afﬁnity
selection showed that B complexes formed in mock-depleted
extract peaked in fractions 14–16 (i.e. the 45S region of the gra-
dient), while ΔSmu1/RED complexes peaked in fractions 12–14,
and thus possess a smaller S-value (Fig. 5a). This could be due to
the presence of fewer proteins/snRNAs and/or to a less compact
structure. However, the snRNA composition of the ΔSmu1/RED
complexes was identical to that of the kinetically-stalled B com-
plexes, which contained stoichiometric amounts of the U2, U4,
U5 and U6 snRNAs, and trace amounts of the U1 snRNA
(Fig. 5b), which is characteristic for B complexes. The presence of
U4 shows that the Brr2-mediated unwinding of the U4/U6
helix has not yet occurred. Thus, depletion of Smu1/RED stalls
spliceosome assembly after Prp28-mediated displacement of U1
(i.e. stable B complex formation), but before the ﬁrst step of the
activation process, namely, unwinding of the U4/U6 duplex by
Brr2.
MS analysis indicated that U2, U5 and U4/U6 snRNP proteins
are present in similar amounts (based on peptide counts) in the
ΔSmu1/RED and kinetically-stalled B complexes (Supplementary
Data 3). Only few Smu1 and RED peptides were detected in
ΔSmu1/RED-B complexes, consistent with their efﬁcient deple-
tion, while the level of all other B-speciﬁc proteins remained
essentially unchanged. Splicing factors that stably integrate
during spliceosome activation—e.g. Prp19/CDC5L complex or
Bact proteins—were underrepresented, consistent with the
ΔSmu1/RED spliceosomes being stalled prior to activation. Thus,
Smu1/RED depletion does not lead to major changes in
spliceosome composition (other than loss of Smu1/RED), but
potentially affects the structure of the B complex, as evidenced by
its lower S-value.
Physical separation of the 5′SS and BS restores activation. In
contrast to long introns, which offer more ﬂexibility, steric hin-
drance may arise from the physical constraints exerted by small
introns, preventing spliceosomes assembled in the absence of
Smu1/RED to adopt a conformation compatible with their sub-
sequent activation. To test this idea, we released any potential



























































Fig. 3 The distance between the 5′SS and BS determines whether splicing is Smu1/RED-dependent. a Schematic of PM5-211 and PM5-116 pre-mRNAs. The
variable region is illustrated in orange. The lack of a 3′ exon stalls splicing after the ﬁrst catalytic step (i.e. at the C complex). b, c Kinetics of in vitro splicing
(b) and spliceosome assembly (c) in the presence or absence of Smu1/RED. 32P-labelled PM5-211 and PM5-116 were incubated under splicing conditions in
the presence of mock-depleted or Smu1/RED-immunodepleted HeLa nuclear extract for 0–120min. The pre-mRNA and splicing intermediates, as well as
spliceosomal complex formation were analysed as in Fig. 2. d Quantiﬁcation of the percent of spliced mRNA generated with the PM5-211 and PM5-116 pre-
mRNAs in Mock- or ΔSmu1/RED-depleted extract. Error bars represent the standard deviation obtained from two independent experiments. Source data
are provided as a Source Data ﬁle
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transcribing MINX80 in two independent parts (cut-MINX80)
(Fig. 6a). The ﬁrst comprised the 5′ exon plus 25 downstream
intron nucleotides, and the second contained 31 nucleotides
upstream of the BS, the BS, PPT and 3′ exon. As in this case only
the 5′ exon is radiolabelled, the intron-3′ exon intermediate and
spliced out intron are not detectable in in vitro splicing assays. In
mock-depleted extract, splicing was less efﬁcient with the cut
versus intact MINX80, which is typical for trans-splicing (i.e.
splicing of physically separated 5′ and 3′ substrates); there also
appeared to be fewer A and B complexes formed, and an
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accumulation of Bact/C complexes with the cut substrate
(Fig. 6b, c). Whereas the splicing of intact MINX80 was much less
efﬁcient in ΔSmu1/RED extract compared to mock, similar levels
of mRNA were formed in both extracts with the cut-MINX80
RNA (Fig. 6b). In addition, the strong accumulation of B com-
plexes in ΔSmu1/RED extract was less severe with the cut-
MINX80 (Fig. 6c). These results suggest that when the distance
between the 5′SS and BS is short (i.e. ca 56 nts), physical con-
straints hinder the B to Bact transition, but even more so when
Smu1 and RED are absent. This in turn suggests that Smu1 and
RED promote the formation of a B complex conformation that is
favourable for its activation and aid in relieving constraints that
hinder activation when the 5′SS to BS distance is short.
Smu1 and RED knockdown hinders Bact formation in HeLa
cells. To determine whether Smu1 and RED depletion also
hinders spliceosome activation in vivo, we knocked down either
Smu1, RED or, as a control, the B-speciﬁc Prp38 protein in
HeLa cells by siRNA transfection. Cell nuclear extracts were
fractionated into a soluble fraction and an insoluble fraction
containing the chromatin-associated material. Phosphorylation
of Prp31 occurs ﬁrst during B complex formation30 and Prp31 is
then released during activation, whereas hyperphosphorylation
of SF3B1 is ﬁrst observed in Bact complexes, and persists until
step 2 of splicing31,32. Thus, antibodies directed against a
phosphorylated form of Prp31 (P-Prp31) or SF3B1 (P-SF3B1)
can be used to determine the relative amounts of B complexes
or Bact/C complexes, respectively, present in a given sample.
P-Prp31 and P-SF3B1 were detected by Western blot primarily
in the chromatin fraction (Fig. 7a, b), consistent with previous
studies showing that approximately 80% of splicing events occur
co-transcriptionally while the nascent transcript is still in the
process of being transcribed by RNA polymerase II31,33,34.
Human Prp38, like its yeast counterpart appears to be required
for spliceosome activation12. In ΔPrp38 cells, the P-Prp31 signal
in the chromatin fraction was stronger compared to that in
control cells, whereas the chromatin-associated P-SF3B1 signal
was reduced (Fig. 7a, c, d). This indicates that there is a block
or slowdown in the B to Bact transition (i.e. spliceosome acti-
vation), as opposed to a general reduction in spliceosome
assembly. A similar increase in the P-Prp31 signal and decrease
in P-SF3B1 signal in the chromatin fraction was observed in
ΔSmu1 and ΔRED cells (Fig. 7b–d), indicating a reduction in the
amount/rate of transformation of B complexes into Bact/C
complexes in vivo upon Smu1 or RED knockdown. These data
suggest that the splicing changes detected by RNA-Seq in Smu1-
and RED-depleted cells might, at least in part, be due to a less
efﬁcient/slower spliceosome activation step.
Fig. 4 Restoration of splicing activity to ΔSmu1/RED extract requires the addition of both proteins. a, b In vitro splicing (a) and the assembly of
spliceosomal complexes on MINX80 pre-mRNA (b) are restored after addition of puriﬁed Smu1/RED dimer to ΔSmu1/RED HeLa nuclear extract. The pre-
mRNA and splicing intermediates and products, as well as spliceosomal complex formation were analysed as in Fig. 2. c Smu1 (blue) and RED (purple)
bridge the U5 Brr2 helicase (brown) and U2 snRNP SF3B3 protein (green) in the human B complex. In the 3D model of the B complex generated by Cryo-
EM29, only the N-terminal region (NTR) and C-terminal WD40 domain of Smu1, plus a short alpha helix of the RED protein that interacts with the Smu1
NTR, could be localised between Brr2 and the WD40-2 domain of SF3B3. d, e In vitro splicing (d) and spliceosome assembly (e) on MINX80 pre-mRNA
after addition of either puriﬁed Smu1 or RED alone, both individual proteins (Smu1 and RED), or puriﬁed Smu1/RED dimer (as indicated above each gel).
f Efﬁcient incorporation of Smu1 or RED into spliceosomal B complexes requires the presence of both proteins. B complexes formed in ΔSmu1/RED HeLa
nuclear after addition of puriﬁed Smu1 or RED alone or both proteins (as indicated above) were afﬁnity puriﬁed and the presence of Smu1 and RED, or of
SF3B1 and Prp31, which served as loading controls, was analysed by Western blot using antibodies against the proteins indicated on the left. Source data
are provided as a Source Data ﬁle. Panel (a) was reprinted from Bertram, K. et al. Cryo-EM structure of a pre-catalytic human spliceosome primed for
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Fig. 5 Characterisation of B complexes that accumulate in the absence of Smu1 and RED. a Glycerol gradient sedimentation proﬁle of spliceosomal
complexes assembled after 8 min on MINX80 in mock-depleted or Smu1/RED-depleted extract. The amount of the 32P-pre-mRNA in each gradient
fraction was determined by Cherenkov counting. b RNA composition of B complexes assembled on MINX80 in mock- or Smu1/RED-depleted extract.
Wildtype or ΔSmu1/RED spliceosomal complexes peaking in gradient fractions 14–16 or 12–14, respectively, were subjected to MS2 afﬁnity puriﬁcation,
and the extracted RNA was analysed by denaturing PAGE followed by SYBR gold staining. The position of the pre-mRNA and UsnRNAs is shown on the
left. Source data are provided as a Source Data ﬁle
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Discussion
Here, we investigated the function of the B-speciﬁc proteins Smu1
and RED in pre-mRNA splicing via a combination of in vivo and
in vitro approaches. Our studies reveal that they not only play
important roles during alternative splicing, but also function as
general splicing factors, facilitating the activation of the human
spliceosome. Several potential mechanisms exist whereby Smu1
and RED might affect spliceosome activation. Protein–protein
crosslinking of puriﬁed human B complexes revealed that Smu1
and RED contact multiple proteins within the spliceosome29.
Thus, Smu1 and RED were proposed to act as binding platforms
for other spliceosomal proteins20,21 and their absence could
potentially affect the recruitment of other proteins important for
spliceosome activation. However, with the exception of the
absence of Smu1/RED, the composition of ΔSmu1/RED B com-
plexes was essentially identical to B complexes assembled in
mock-depleted extract. Thus, the recruitment of B complex
proteins is not dependent on Smu1/RED and the less efﬁcient
activation observed in their absence is not due to the absence of
other proteins. However, we cannot rule out that depletion of
Smu1 and RED alters protein–protein or protein–RNA interac-
tions within the spliceosome. Indeed, ΔSmu1/RED B complexes
exhibited an aberrant sedimentation behaviour on glycerol gra-
dients, suggesting structural changes in the spliceosome, in par-
ticular a less compact conformation. Future cryo-EM of ΔSmu1/
RED B complexes may allow insights into the nature of structural
changes that may arise due to the absence of these proteins.
Spliceosome activation is initiated by Brr2-mediated unwind-
ing of the U4/U6 duplex. As Brr2 is a stable component of the
spliceosome prior to activation, its activity must be tightly regu-
lated to prevent premature activation. Several mechanisms
repress Brr2 activity prior to activation, and its RNA unwinding
activity must be triggered, by a currently unknown mechanism, to
start the activation process35. Smu1 and RED bridge Brr2 and the
U2 protein SF3B3 in the B complex, with Smu1 directly con-
tacting the N- and C-terminal helicase cassettes of Brr2. Thus,
these proteins could help to position Brr2 relative to its substrate
in a way that promotes U4/U6 unwinding. Consistent with this
idea, Brr2 is very ﬂexible and undergoes a large scale movement
from its position in the tri-snRNP to its position close to U4/U6
in the B complex29, and Smu1 and RED could help to anchor
Brr2 in this position. Enhanced Brr2 and/or U2 ﬂexibility could
also explain why B complexes lacking Smu1/RED appear to have
a less compact structure. Furthermore, as Smu1’s WD40 domain
is positioned at the interface of Brr2’s N- and C-terminal helicase
cassettes, it could also potentially modulate Brr2’s helicase
activity.
Introns retained after knockdown of Smu1 or RED were pre-
dominantly shorter than 200 nts. Nonetheless, a substantial
fraction (30–40%) of the retained introns were signiﬁcantly
longer, consistent with a general requirement for Smu1 and RED
for efﬁcient splicing also of longer introns. In vitro splicing stu-
dies using truncated versions of MINX120 pre-mRNA, also
demonstrated that spliceosome activation is more dependent on
Smu1 and RED when intron length is shorter. Our data further
indicate that the 5′SS–BS distance, rather than intron length
per se, is a decisive factor for whether or not activation is strongly
dependent on Smu1/RED. In the human B complex, a 17 nt long
extended helix is formed between the U6 ACAGA box plus
adjacent U6 nucleotides and intron nucleotides near the 5′SS29.
Similarly, the BS and intron nucleotides upstream of it, form a
14 nt long helix with U2 snRNA29,36,37. In human B complexes
formed on MINX120 pre-mRNA, these two extended helices are
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Fig. 6 Cleavage of the MINX80 intron restores spliceosome activation in ΔSmu1/RED nuclear extract. a Schematic of the MINX80 and cut-MINX80 pre-
mRNAs. Cut-MINX80 was generated by transcribing the MINX80 pre-mRNA in two parts, where only the 5′ half was 32P-radiolabelled (indicated in red).
b, c Kinetics of in vitro splicing (b) and spliceosome assembly (c) of the MINX80 and cut-MINX80 pre-mRNAs in mock- and Smu1/RED-depleted extract.
The pre-mRNA and splicing intermediates/products, as well as spliceosomal complex formation, were analysed as in Fig. 2. Source data are provided as a
Source Data ﬁle
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RNA in an extended conformation. Consequently, to span the
distance between the 5′SS and BS, without altering the structure
of the spliceosome, a minimum of ~52 intron nts would be
necessary. This is approximately the distance found in the
MINX80 and PM5-116 pre-mRNAs, suggesting that intron
nucleotides between the extended U6/5′SS helix and U2/BS
helices are likely in a fully-extended conformation in B complexes
formed on these pre-mRNAs. This could limit the ﬂexibility of
the spliceosome during its remodelling, thereby impeding or—in
the absence of Smu1/RED—completely preventing its activation.
Consistent with this, physically separating the 5′SS and BS to
release any length limitations, restored the transformation of B
complexes into Bact.
By combining the data presented here and information about
the structure of the human B complex, we generated a model for
how the 5′SS–BS distance might lead to the dependency of spli-
ceosome activation on Smu1/RED (Fig. 8b). In the human B
complex, Smu1 and RED form a molecular bridge between the
U2 snRNP and tri-snRNP29. In the yeast spliceosome, which
lacks Smu1 and RED, this bridge is formed directly by the Brr2
and SF3B3 homologs38 (Supplementary Fig. 6). Here, a WD40
domain of Rse1, the yeast counterpart of SF3B3, contacts the two
helicase cassettes of Brr2, whereas in the human B complex the
WD40 domain of Smu1 contacts them. This interaction likely
stabilises the position of Brr2 relative to its U4/U6 substrate or
might even directly stimulate Brr2 activity thereby promoting
activation. In the human spliceosome, Smu1 and RED could
ensure that the contact between U2 snRNP and Brr2 is estab-
lished faster and remains stable during activation. As longer
introns allow spliceosome activation in the absence of Smu1 and
RED, but with reduced efﬁciency, it appears that a sufﬁciently
long intron grants the U2-containing head domain of the B
complex enough ﬂexibility to move towards Brr2, coincidentally
forming the apparently essential SF3B3-Brr2 bridge, only at a
slower pace (Fig. 8b). In contrast, an intron with a critical 5′
SS–BS distance of ~56 nt would be completely extended between
those nucleotides forming a duplex with U2 or U6, and therefore
physically restrict the mobility of U2. This would prevent the
movements necessary for U2 SF3B3 to contact Brr2, and this
would be most severe when Smu1 and RED are absent (Fig. 8b).
In this case, physically separating 5′SS and BS would release this
physical constraint. Consequently, the ﬂexibility of U2 that allows
it to move towards Brr2 would be restored, allowing spliceosome
activation even without Smu1 and RED.
Previous studies, as well as data presented here, demonstrate
that Smu1 and RED affect the outcomes of many alternative
splicing events. Our data showing an effect of Smu1 and RED
depletion on the rate of spliceosome activation and that introns
with a short 5′SS–BS distance are especially dependent on Smu1/
























































































Fig. 7 Smu1 and RED knockdowns alter the levels of phosphorylated Prp31 and SF3B1 in vivo. a, b Control HeLa cells (CTRL) or cells depleted of a Prp38 or
b Smu1 and RED by RNAi were fractionated into a soluble (Sol) or chromatin (Chr) fraction. Equal amounts of each fraction were analysed by Western blot
using antibodies against phosphorylated (P) SF3B1 or phosphorylated Prp31, SF3B1 (both phosphorylated and non-phosphorylated), Histone 3B (H3), RED,
Smu1 or Prp38. c, d Quantiﬁcation of phosphorylation levels of c Prp31 or d SF3B1 in CTRL or knockdown cells as indicated on the X-axis. The signal of the
corresponding protein in the control lane was set to 100%. Error bars represent the standard deviation obtained from two independent experiments. The
enhanced P-SF3B1 signal in the soluble nuclear fraction after Smu1 knockdown is likely due to dissociation during fractionation of less stable spliceosomes
leading to leakage. Data points are shown as black dots. Error bars represent the standard deviation obtained from two independent experiments. Source
data are provided as a Source Data ﬁle
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knockdown affects alternative splicing in vivo. For example, the
use of an alternative upstream 5′SS would expand the 5′SS–BS
distance of an alternatively spliced intron, and thus usage of a
more distal 5′SS would be favoured after Smu1/RED knockdown
in those cases where this distance is short. As alternative 3′SS
usage often also involves the use of an alternative BS, the same
may also be true when a downstream 3′SS is preferentially used in
Smu1/RED-depleted cells. Transcription and splicing are tem-
porally and functionally linked; splice site recognition by splicing
factors and thus the assembly of a spliceosome at a particular
splice site are affected by the pace of RNA Pol II elongation,
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sequences appear in nascent pre-mRNAs (reviewed in ref. 39). In
many cases, slowing the rate of RNA Pol II elongation favours the
use of weaker upstream splice sites40,41. A slowed-down rate of
spliceosome assembly and/or activation could enhance the use of
weaker splice sites that are normally skipped in favour of stronger
splice sites when the spliceosome assembly process is very fast.
Thus, some changes in alternative splicing observed by RNA-seq
analyses in Smu1- and RED-depleted cells might be due to a
general slow-down in the formation of catalytically active spli-
ceosomes. Although splice site selection is often determined prior
to B complex formation, and thus prior to the recruitment of
Smu1 and RED, some splice site choices appear to be made after
A complex formation42–44. In addition, most spliceosome
assembly steps are reversible43,45, and stalling at the B complex
stage would likely also lead to enhanced dissociation and refor-
mation of the spliceosome, which could also lead to altered splice
site selection when Smu1 and RED are knocked down. Results
from genome-wide screens and functional network reconstruc-
tions in multiple organisms indicate that changes in the activity of
core splicing factors can inﬂuence alternative splicing15,46–49.
Differential effects on splicing in other tissues may also arise due
to differences in the expression levels of Smu1 and/or RED, where
low levels of these proteins may become rate-limiting, leading to
even more pronounced effects.
Methods
siRNA sequences. For RNA-Seq analysis, HeLa cells were transfected with siRNAs




Prp38: CTGCTGTTATTCAAAGATCAA; TCCACGGACATCGATAATCAA. A
control siRNA with no target in the human transcriptome was also transfected.
Cells were harvested 50 h post-siRNA transfection and their total RNA was
extracted and reverse transcribed.
RNA-Seq read alignment. Pair ended read libraries for the assayed condition were
produced using the Trueseq v3 HiSeq sequencing kit. After de-multiplexing, the
reads (pair-ended, 100 nt) were aligned against the human genome (version
GRCh37/hg19) using tophat50 version 2.08 with command line parameters: --no-
discordant --no-mixed --library-type fr-ﬁrststrand --mate-std-dev 85 -i 20 -I
800000 -x 5. In total ~900 million reads, or ca 225 million reads per condition, were
aligned to the genome and the resulting bam ﬁles were used as input for the
detection and quantiﬁcation of alternative splicing and intron retention events.
Quantiﬁcation of alternative splicing events. Quantiﬁcation of alternative spli-
cing events was performed using a junction-centric approach that fuses available
transcript structure information with experimental junction evidence. As our
approach does not fully rely on existing splicing annotation it is capable of iden-
tifying novel splicing events that are absent in transcriptome databases. This is
critical in experiments, such as those performed in this study, where drastic per-
turbations of the splicing machinery can result in a large number of novel/aberrant
splicing events. Junction reads were deﬁned as reads mapping discontinuously on
the same gene, interrupted by a gene segment, containing canonical or non-
canonical splice sites. The minimum overhang required for considering a junction
read was set to 3 nucleotides for annotated junctions and 6 nucleotides for novel
junctions. For each junction read a set of neighbouring junction reads were selected
in order to calculate a normalised junction usage efﬁciency. We deﬁned as a
neighbouring junction only those for which all of the following conditions are met:
(i) all known transcripts containing the neighbouring junction must fully subsume
the original junction, (ii) all known transcripts containing the original junction
must fully subsume the neighbouring junction and (iii) the neighbouring junction
is within 5 kb of the original junction. p-Values for the differential usage of a
junction in two conditions were calculated using Fisher’s exact test on the 2 × 2
contingency table containing the counts of a junction and its corresponding
neighbouring junctions in the two conditions. The inclusion of all neighbouring
junctions in the p-value calculation (as opposed to only junctions with common
boundaries as is typical in PSI calculations, see below) reduces sensitivity to
sampling noise and junction mappability differences in the RNA-Seq libraries.
Percent Spliced In indices (PSI) were also calculated for each junction considering
the neighbouring junctions with one common boundary (junction start or junction
end) as:
PSI ¼ mean J
Jsame Start þ J
;
J
Jsame End þ J
 
ð1Þ
Differentially used junctions that can be attributed to alternative splicing were then
selected on the basis of a series of thresholds applied to the previous metrics. For
this study we required a p-value < 0.001, ΔPSI > 0.15 and at least 7 junction reads
supporting the junction in one of the two conditions. Categorisation of the iden-
tiﬁed differential splicing junctions into different splicing competition types was
performed by identifying competing junctions using a greedy local search around
each differential junction. Competition types were classiﬁed as alternative 3′SS (Alt
3′SS), alternative 5′SS (Alt 5′SS), cassette exons (CEx) and complex events, such as
those involving competition among multiple junctions on non-mutually exclusive
junctions.
Detection and quantiﬁcation of intron retention. Detection of intron retention
events relies on two lines of evidence that consider both junction and intronic
reads: (i) The presence of a differentially used junction on the basis of the p-value
threshold—see above—without a competing junction and (ii) differential intron
retention (IR) for the intron in question on the basis of intronic read coverage.
After normalising the number of intronic reads to the total number of intronic
reads within an experiment, IR was calculated as the ratio of the strictly intronic
reads covering a segment of the intron over the reads of neighbouring introns (as
deﬁned above) in order to account for intron read coverage shifts resulting from
changes in gene expression. A singe robust IR value per intron was then calculated
as the median of max (2, intron length/500) intronic segments IR values in order to
reduce the number of false positives due to differential coverage in small portions
of the intron. Such small spikes of intronic read coverage within larger introns can
be products of intron-contained transcribed units such as unannotated exons,
overlapping genes or autonomously transcribed transposable elements. A p-value
for differential intron retention was ﬁnally calculated using Fisher’s exact test on
the 2 × 2 contingency table containing the intronic counts for the segments of an
intron in question and the corresponding neighbouring intronic reads from the two
conditions. In addition to the p-value threshold for a differentially used junction
(deﬁned above) supporting intron retention we require at least a 2-fold change in
IR and a p-value for differential intron retention <0.001 in order to consider an
intron as differentially retained in two conditions. The code for the detection and
quantiﬁcation of alternative splicing events and the detection and quantiﬁcation of
intron retention is available as a single perl package in https://github.com/
ppapasaikas/SANJUAN.
Analysis of 5′SS–branch site (BS) distances. For the analysis of 5′SS–BS dis-
tances, BS data were obtained from the genome wide study by Pineda and
Fig. 8Model for how the 5′SS–BS distance leads to the dependence of spliceosome activation on Smu1/RED. a Distance between 5′SS and BS in the human
B complex29. Left, overview of the complete human B complex. Right, expanded view of the upper region where intron nucleotides between the 5′SS and BS
should be located in short introns. The intron (red solid line) forms extended helices with the U6 ACAGAG box and adjacent U6 nucleotides (yellow) at the
5′SS and the U2 snRNA (green) at the BS. The two helices are separated by 15 nm (ca 21 nt, red dashed line) in the human B complex. This would
accommodate an estimated minimum of 52 nt between the 5′SS and the BS, without altering the structure of the spliceosome. bModel of the role of Smu1
and RED in the B complex. Upper left, Smu1/RED supports/stabilises the formation of the Brr2-U2 bridge, which is likely important for spliceosome
activation. In the absence of Smu1/RED, this bridge can still be formed, albeit at a slower rate, as long as the distance between the 5′SS and BS is
sufﬁciently long to allow movement of the U2 domain towards Brr2, resulting in a direct Brr2-U2 interaction. Lower left, when the distance between the 5′
SS and the BS is short, the U2 snRNP may be repositioned and/or its ability to move towards Brr2 may be inhibited due to the structural constraint of the
intron. Therefore, no direct contact between U2 and Brr2 can be established, and Smu1 and RED become essential for activation. Lower right, splitting the
MINX80 pre-mRNA into two pieces may relieve this constraint, allowing the B-to-Bact transition even in the absence of Smu1 and RED. Panel (a) was
reprinted from Bertram, K. et al. Cryo-EM structure of a pre-catalytic human spliceosome primed for activation. Cell 170, 701–713 (2017), with permission
from Elsevier
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Bradley51. The high and moderate conﬁdence collection of human branch sites was
overlapped with the collection of identiﬁed introns of this study. In cases where
multiple BSs were linked to the same 5′SS of an intron, only the BS with the highest
number of sequenced lariats with a mismatch at the BS nucleotide was considered.
Of the ~80,000 introns that were conﬁdently identiﬁed in this study, information
about the BS was available for ~58% of them. This percentage was lower for shorter
introns (e.g. 45% for introns <250 nt, 27% for introns <100 nt). Similar detection
biases were also seen in other genome wide studies of human branch sites52,53.
Relevant to this study, this detection asymmetry means that the observed bias for
short 5′SS–BS distances in the pool of ΔSmu1/ΔRED retained introns is under-
estimated. Testing for differences in the distributions of 5′SS–BS distances between
retained and unaffected introns was done using the two-sided, two-sample
Smirnov–Kolmogorov test. For the unaffected introns, we used a sample of introns
with matching length distributions to the retained introns with an oversampling
factor of 5.
Preparation of nuclear extract and Smu1/RED immunodepletion. For pre-
paration of nuclear extract52 HeLa S3 cells (Helmholtz Center for Infection
Research, Braunschweig) were pelleted by centrifugation in a Megafuge (Heraeus)
at 2000 × g and 4 °C for 10 min. After two washes with 1× PBS (130 mM NaCl, 27
mM KCl, 8.0 mM Na2HPO4, 1.5 mM KH2PO4), cells were resuspended in 1.25
volumes MC Buffer (10 mM HEPES, pH 7.6, 10 mM KOAc, 0.5 mM Mg(OAc)2
and freshly added 5 mM dithiothreitol (DTT) and 1× cOmplete™, EDTA-free
Protease Inhibitor Cocktail). Cells were incubated on ice for 5 min and dounced 18
times (Pestel B).
The extract was transferred to 50mL falcon tubes and centrifuged in a F14-14 ×
50cy rotor (Sorvall LYNX 6000 Superspeed Centrifuge) at 4 °C and 18,000 × g for 5
min. The pellet was resuspended in 1.3 volumes of Roeder C Buffer (25% glycerol,
20 mM HEPES-KOH, pH 7.9, 420mM NaCl, 1.5 mM MgCl2, 0.2 mM EDTA-KOH,
pH 8.0), and freshly added 0.5 mM dithioerythriol (DTE) and
phenylmethanesulfonyl ﬂuoride (PMSF) and dounced 20 times (Pestel B). The
extract was kept in a beaker at 4 °C for 40 min and then transferred to a 50mL
falcon tube and centrifuged at 26,048 × g for 30min at 4 °C in a F14-14 × 50cy rotor
(Sorvall LYNX 6000 Superspeed Centrifuge). The nuclear extract (supernatant)
was ﬁlled into fresh 50mL falcon tubes and frozen in liquid nitrogen for storage at
−80 °C or dialysed against Roeder D Buffer (20mM HEPES-KOH, pH 7.9, 100mM
KCl, 1.5 mM MgCl2, 0.2 mM EDTA-KOH, pH 8.0) and freshly added 0.25 mM
DTT and 0.25 mM PMSF. Immunodepletion of Smu1/RED from HeLa nuclear
extract was performed using anti-peptide antibodies speciﬁc for Smu1, which were
covalently crosslinked to Protein A Dynabeads (Thermo Fisher) using dimethyl
pimelimidate (DMP). The anti-Smu1 beads were washed 3× with PBS and then
blocked overnight in PBS supplemented with 0.5mg/mL BSA, 0.05 mg/mL
Escherichia coli tRNA and 0.05 mg/mL glycogen. The salt concentration of the
nuclear extract was increased to 750mM KCl. After three washes with Roeder D
buffer containing 750mM KCl (RD-750) (20mM Hepes-KOH, pH 7.9, 750mM
KCl, 1.5 MgCl2, 0.2.mM EDTA, pH 8.0), 0.25 mM DTT, 0.25 mM PMSF, the beads
were divided into two equal portions and the nuclear extract was incubated with
each portion for 2 h at 4 °C with head-over-tail rotation. The nuclear extract was
subsequently dialysed against RD-100 buffer for 5 h at 4 °C. Mock-depleted extract
was treated in an identical manner, except the antibody was omitted.
Puriﬁcation of recombinant Smu1, RED or Smu1/RED dimer. Smu1 and RED
were expressed separately or co-expressed in Sf9 (Thermo Fisher Scientiﬁc,
Cat#11496015) or High Five (Thermo Fisher Scientiﬁc, Cat#B85502) cells using
synthetic genes optimised for expression (GeneArt, Life Technologies). To purify
the dimer, RED was tagged with an N-terminal poly-His10 tag and Smu1 was
tagged with a C-terminal Strep-II tag. For the isolation of Smu1 alone, it was tagged
with an N-terminal His10 tag (EcoRI/PstI), which allowed more efﬁcient pur-
iﬁcation than the Strep-II tag. Plasmids encoding Smu1 or RED were transformed
into DH10MultiBacY cells to generate baculoviral DNA. The latter was transfected
in Sf9 insect cells grown in Gibco® Sf-900™ III SFM medium, using X-tremeGENE™
9 DNA Transfection Reagent according to the manufacturer protocol. 60–72 h after
transfection, the virus containing supernatant was collected (V0). Fresh Sf9 cells
were subsequently transfected to generate the V1 virus. For protein expression, the
optimised High FiveTM cell line was used. The cells were maintained in suspension
in ESF 921 Insect Cell Culture Medium and were harvested 60–72 h after virus
transfection. The High FiveTM cell pellet was resuspended in pre-chilled High Five
Lysis Buffer (50 mM Hepes-KOH, pH 7.9, 500 mM NaCl, 15 mM imidazole, 0.1%
NP-40, 15% (v/v) glycerol, 2 mM DTT) (10 mL/g cells) and disrupted by ultrasonic
probe sonication at 30% amplitude for 15–30 min (30 ms on, 30 ms off) until the
lysate was clear. After centrifugation for 1 h at 17,000 × g in a F14-14 × 50cy rotor
(Sorvall LYNX 6000 Superspeed Centrifuge) at 4 °C, the soluble cell fraction was
diluted 1:1 with High Five Dilution Buffer (50 mM Hepes-KOH, pH 7.9, 50 mM
NaCl, 15% (v/v) glycerol, 2 mM DTT) and incubated with previously equilibrated
Roti®garose-His/Ni Beads (Roth) at 4 °C for 3 h with head-over-tail rotation. The
beads were collected and washed 3× with High Five Wash Buffer (50 mM Hepes-
KOH, pH 7.9, 750 mM NaCl, 20 mM imidazole, 15% (v/v) glycerol, 2 mM DTT)
for 10 min at 4 °C with head-over-tail rotation. Elution was performed with 1.5–3
bead volumes of High Five Elution Buffer (20 mM Hepes-KOH, pH 7.9, 200 mM
NaCl, 300 mM imidazole, 15% (v/v) glycerol, 2 mM DTT) on ice for 15 min.
Puriﬁed proteins were analysed by SDS-PAGE, followed by staining with Coo-
massie blue, and the identity of the proteins was conﬁrmed by mass spectrometry.
In vitro splicing and splicing complex formation. Transcription templates for the
MINX70, MINX80, MINX90 and MINX150 pre-mRNAs were generated by PCR
using MINX120 as a template. PM5-211 was generated from the PM5 pre-mRNA
(PM5-211) template in a similar manner. Templates for the 5′ and 3′ halves of
MINX80 (cut-MINX80) were also generated by PCR. MINX80-extPy was obtained
by duplicating a 10 nt stretch (TTTTTTTTCC) located between nucleotides 8 and
18 downstream of the BS and inserted after nucleotide 19. Uniformly 32P-labelled,
m7G-capped pre-mRNA, or non-labelled 3′ half of cut-MINX80, was generated by
in vitro transcription. Splicing reactions contained 40% (v/v) untreated or 50%
(v/v) mock-depleted or Smu1/RED-depleted HeLa nuclear extract, 60 mM KCl,
3 mM MgCl2, 2 mM ATP 20mM creatine phosphate, and 10 nM uniformly 32P-
labelled, m7G-capped pre-mRNA, and were incubated at 30 °C for the indicated
times. In the case of cut-MINX80, splicing was performed with 10 nM of the
radiolabelled 5′ half and 50 nM of the unlabelled 3′ half. For splicing com-
plementation experiments, a 30-fold molar excess of puriﬁed recombinant Smu1 or
RED or Smu1/RED dimer was added to the Smu1/RED-depleted nuclear extract
and preincubated for 15 min at 30 °C. Splicing was initiated by addition of the
radiolabeled MINX-MS2 pre-mRNA. RNA was recovered at the indicated time
points and separated on a 14% denaturing polyacrylamide gel. Unspliced pre-
mRNA and spliced mRNA were detected using a Typhoon phosphoimager (GE
Healthcare) and were quantiﬁed using ImageQuantTL (GE Healthcare). The per-
cent spliced mRNA was calculated by dividing the amount of mRNA by the
amount of pre-mRNA plus mRNA (minus background), and multiplying by 100.
Spliceosomal complexes were analysed by electrophoresis in a 2% (w/v) low
melting agarose gel in TBE buffer (89 mM Tris–HCl, pH 7.5, 89 mM boric acid,
2.5 mM EDTA, pH 8.0) in the presence of 0.5 μg/μl heparin, and bands were
visualised with a Typhoon phosphoimager (GE Healthcare).
MS2 afﬁnity selection and mass spectrometry. For puriﬁcation of spliceosomal
complexes53, the pre-mRNA was pre-incubated with a 20-fold molar excess of
puriﬁed MS2-MBP fusion protein and subsequently added to a 1 mL standard
splicing reaction. Mock (kinetically-stalled) and ΔSmu1/RED B complexes were
incubated for 8 min at 30 °C. The splicing reaction was loaded onto a 14 mL linear
10–30% (v/v) glycerol gradient containing G-150 buffer. Gradients were cen-
trifuged at 60,000 × g for 15 h 20 min at 4 °C in a Sorvall TST 41.14 rotor, and
500 µl gradient fractions were harvested manually from the top. The distribution
of 32P-labelled pre-mRNA was analysed by Cherenkov counting. For afﬁnity
selection, the peak fractions containing the respective spliceosomal complexes were
pooled and loaded onto an amylose column (NEB). After washing with 50 column
volumes of G-75 buffer (20 mM HEPES-KOH, pH 7.9, 1.5 mM MgCl2, 75 mM
KCl), spliceosomal complexes were eluted by addition of G-75 buffer containing
25 mM maltose. The RNA composition was analysed by denaturing
polyacrylamide-gel electrophoresis, followed by staining with SYBR® Gold. Proteins
were separated on 4–12% NuPAGETM gradient gels (Invitrogen), digested with
trypsin, and peptides were analysed on an Q Exactive™ HF Hybrid Quadrupol-
Orbitrap™ Mass Spectrometer (Thermo Fisher Scientiﬁc) under standard condi-
tions. Proteins were identiﬁed by searching fragment spectra against UniProt
(universal protein database) using Mascot as a search engine.
siRNA-mediated knockdowns and cell fractionation. HeLa SS6 cells (ATCC,
USA) were grown in 10 cm dishes containing Dulbecco’s Modiﬁed Eagle’s Medium
(DMEM) supplemented with 10% fetal bovine serum (FBS) and 100 µg/mL peni-
cillin/streptomycin. The latter was omitted prior to transfecting the cells with a
control siRNA, or siRNAs against Smu1, RED or Prp38, which was performed
using the Lipofectamine® RNAiMAX Transfection Reagent (Thermo Fisher Sci-
entiﬁc). 60 h after siRNA transfection, cells were washed twice with ice-cold 1× PBS
and then HeLa Cell Lysis Buffer [2 mM EDTA, pH 8.0, 150 mM NaCl, 1 mM
MgCl2, 30 mM Tris–HCl, pH 7.5, 1% (v/v) Triton X-100, 2× Complete Protease
inhibitor (Roche), 2× PhosSTOP (Roche)] was added (~10 × 106 cells/mL buffer).
After brief vortexing, the samples were incubated on ice for 15 min. The nucleo-
plasmic fraction was separated from the chromatin fraction by centrifugation at
1100 × g for 10 min at 4 °C. The soluble fraction was collected and the pellet
containing the chromatin fraction was resuspended in HeLa Cell Lysis Buffer in a
volume equivalent to the soluble fraction. The chromatin was solubilized by
sonication in a Bioruptor for 3 min (30 s on, 30 s off) at maximum intensity in a
water bath at 2 °C. The protein concentration was determined using a BCA Protein
Assay Kit (Thermo Fisher Scientiﬁc). The protein composition of the soluble and
chromatin fractions was analysed by western blotting.
Western blotting. For western blotting, proteins were separated by SDS-PAGE and
transferred to a nitrocellulose membrane (Protran, Whatman). The blocked mem-
brane was incubated with antibodies against the following human proteins Smu1
(1:1000; sc-100896—Santa Cruz Biotechnology, USA), Histone H3B (1:5000; ab18521
—Abcam, UK), RED (1:1000; Lührmann Laboratory), FBP21 (1:1000; sc-84249 Santa
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Cruz Biotechnology, USA), Prp38 (1:3000; Lührmann Laboratory)12, MFAP1 (1:1000;
Lührmann Laboratory), Snu114 (1:1500; Lührmann Laboratory)54, SF3A2 (1:2000;
Lührmann Laboratory) and SF3B1 (1:1000; Lührmann Laboratory)55, Snu66 (1:2000;
Lührmann Laboratory)56, phosphorylated SF3B1 (1:1500; Lührmann Laboratory)31,
Prp31 (1:1000; Lührmann Laboratory)57, phosphorylated Prp31 (1:2000; Lührmann
Laboratory)30. As secondary antibody horseradish-peroxidase-conjugated Goat-anti-
rabbit (1:50,000; 111-035-144—Jackson Immunoresearch, USA) or Goat-anti-mouse
(1:10,000; 115-035-003—Jackson Immunoresearch, USA) antibodies were used and
bound antibody was detected using an ECL detection kit (GE Healthcare).
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
A reporting summary for this Article is available as a Supplementary Information ﬁle.
The source data underlying Figs. 2b–d, 3b–d, 4a, b, d–f, 5b, 6b, c, 7a–d, and
Supplementary Figs. 1a, b, 2a–c, 3a, 4b, c, 5b–e, as well as Supplementary Data 3, are
provided as a Source Data ﬁle. Data that support the ﬁndings of this study have been
deposited in the ebi ArrayExpress Archive of Functional Genomics Data repository.
Accession code E-MTAB-7522. All data is available from the corresponding author upon
reasonable request.
Code availability
The code used for the detection and quantiﬁcation of alternative splicing events and
intron retention is available as a single perl package in https://github.com/ppapasaikas/
SANJUAN.
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